CLINICAL TRIALS PROFILE FOR OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
✉ Email this page to a colleague
All Clinical Trials for OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004363 ↗ | Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus | Completed | Northwestern University | 1995-12-01 | OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II (AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by directing the production of an abnormal preprohormone. II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys magnocellular neurons because it cannot be folded and processed efficiently. | |
| NCT00004363 ↗ | Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus | Completed | National Center for Research Resources (NCRR) | 1995-12-01 | OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II (AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by directing the production of an abnormal preprohormone. II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys magnocellular neurons because it cannot be folded and processed efficiently. | |
| NCT00107874 ↗ | Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section | Completed | Basel Women’s University Hospital | Phase 2 | 1999-01-01 | Postpartum hemorrhage (PPH) ranks among the leading causes of maternal morbidity and mortality, both in developed and developing countries. With this trial, we sought to determine the effectiveness of oral misoprostol as an uterotonic drug in comparison with intravenous oxytocin, in patients with a low risk of PPH undergoing non-scheduled Cesarean section. We therefore compared the intra- and postoperative blood loss, as well as drug related side effects in patients, treated by the same surgical and anesthesiological team in one institution. |
| NCT00107874 ↗ | Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section | Completed | University Hospital, Basel, Switzerland | Phase 2 | 1999-01-01 | Postpartum hemorrhage (PPH) ranks among the leading causes of maternal morbidity and mortality, both in developed and developing countries. With this trial, we sought to determine the effectiveness of oral misoprostol as an uterotonic drug in comparison with intravenous oxytocin, in patients with a low risk of PPH undergoing non-scheduled Cesarean section. We therefore compared the intra- and postoperative blood loss, as well as drug related side effects in patients, treated by the same surgical and anesthesiological team in one institution. |
| NCT00114439 ↗ | Lithium Cannabis Withdrawal Study | Completed | The University of New South Wales | Phase 2 | 2005-09-01 | This trial will examine the efficacy of lithium in providing symptomatic relief from the withdrawal discomfort experienced by some dependent users of cannabis on cessation of regular use. Significant withdrawal may be a barrier to achieving abstinence in some clients and can be associated with marked disturbances in mood, sleep, hostility and aggression. Relief from such symptoms may be important in helping some clients achieve a period of abstinence and facilitate subsequent entry into a relapse prevention program. |
| NCT00114439 ↗ | Lithium Cannabis Withdrawal Study | Completed | Sydney South West Area Health Service | Phase 2 | 2005-09-01 | This trial will examine the efficacy of lithium in providing symptomatic relief from the withdrawal discomfort experienced by some dependent users of cannabis on cessation of regular use. Significant withdrawal may be a barrier to achieving abstinence in some clients and can be associated with marked disturbances in mood, sleep, hostility and aggression. Relief from such symptoms may be important in helping some clients achieve a period of abstinence and facilitate subsequent entry into a relapse prevention program. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
Condition Name
Clinical Trial Locations for OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
Trials by Country
Clinical Trial Progress for OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
Clinical Trial Phase
Clinical Trial Sponsors for OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
Sponsor Name
| Sponsor Name for OXYTOCIN 10 USP UNITS IN DEXTROSE 5% | |
| Sponsor | Trials |
| University of Electronic Science and Technology of China | 40 |
| Samuel Lunenfeld Research Institute, Mount Sinai Hospital | 29 |
| Cairo University | 24 |
| [disabled in preview] | 47 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
